- Home
- HKIT vs GRCE Comparison
HKIT vs GRCE Comparison
Compare HKIT & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- GRCE
- Stock Information
- Founded
- HKIT 1996
- GRCE 2002
- Country
- HKIT China
- GRCE United States
- Employees
- HKIT N/A
- GRCE N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- GRCE
- Sector
- HKIT Technology
- GRCE
- Exchange
- HKIT Nasdaq
- GRCE NYSE
- Market Cap
- HKIT 39.8M
- GRCE 42.1M
- IPO Year
- HKIT 2023
- GRCE N/A
- Fundamental
- Price
- HKIT $1.39
- GRCE $3.07
- Analyst Decision
- HKIT
- GRCE Strong Buy
- Analyst Count
- HKIT 0
- GRCE 1
- Target Price
- HKIT N/A
- GRCE $12.00
- AVG Volume (30 Days)
- HKIT 8.4K
- GRCE 61.9K
- Earning Date
- HKIT 04-29-2025
- GRCE 08-15-2025
- Dividend Yield
- HKIT N/A
- GRCE N/A
- EPS Growth
- HKIT N/A
- GRCE N/A
- EPS
- HKIT N/A
- GRCE N/A
- Revenue
- HKIT $2,904,950.00
- GRCE N/A
- Revenue This Year
- HKIT N/A
- GRCE N/A
- Revenue Next Year
- HKIT N/A
- GRCE N/A
- P/E Ratio
- HKIT N/A
- GRCE N/A
- Revenue Growth
- HKIT N/A
- GRCE N/A
- 52 Week Low
- HKIT $1.15
- GRCE $1.75
- 52 Week High
- HKIT $1.86
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- HKIT 54.63
- GRCE N/A
- Support Level
- HKIT $1.33
- GRCE N/A
- Resistance Level
- HKIT $1.44
- GRCE N/A
- Average True Range (ATR)
- HKIT 0.05
- GRCE 0.00
- MACD
- HKIT 0.00
- GRCE 0.00
- Stochastic Oscillator
- HKIT 61.62
- GRCE 0.00
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.